CD5-positive diffuse large B-cell lymphoma (DLBCL) is a rare variant, representing approximately 5%-10% of all DLBCL cases and is associated with advanced age, extranodal involvement, and poorer prognosis. This evidence concerns the gene CD5 and diffuse large B-cell lymphoma.